60 results on '"Zhi-xian Ruan"'
Search Results
2. Association of Dietary Glycemic Index and Glycemic Load with Endometrial Cancer Risk Among Chinese Women
- Author
-
Hui Cai, Xianglan Zhang, Yong-Bing Xiang, Wanghong Xu, Wei Zheng, Xiao-Ou Shu, and Zhi-Xian Ruan
- Subjects
Adult ,China ,Cancer Research ,medicine.medical_specialty ,Medicine (miscellaneous) ,Gastroenterology ,Article ,Risk Factors ,Surveys and Questionnaires ,Internal medicine ,Glycemic load ,Dietary Carbohydrates ,medicine ,Humans ,Registries ,Aged ,Nutrition and Dietetics ,business.industry ,Endometrial cancer ,Urban Health ,Case-control study ,Oryza ,Odds ratio ,Middle Aged ,Anthropometry ,medicine.disease ,Confidence interval ,Diet ,Endometrial Neoplasms ,Logistic Models ,Glycemic index ,Endocrinology ,Oncology ,Glycemic Index ,Case-Control Studies ,Seeds ,Female ,business - Abstract
We evaluated the association of dietary glycemic index (GI) and glycemic load (GL) with the risk of endometrial cancer in a population-based, case-control study of 1199 endometrial cancer patients and 1212 age-frequency-matched controls in urban Shanghai, China, where diets are typically high in carbohydrates and have a high GL. Information on dietary habits, physical activity, and other relevant information was collected using a validated questionnaire, and anthropometric measurements were taken. Logistic regression was applied in the analysis. Dietary GI and GL were independently associated with risk for endometrial cancer but carbohydrate intake was unrelated to risk. Multivariable-adjusted odds ratios (ORs) for increasing quartiles of intake were 1.0, 1.3, 1.4, and 2.2 [95% confidence interval (CI): 1.2-4.0] for dietary GL (P(trend) = 0.02) and 1.0, 1.2, 1.4, and 1.4 (95% CI: 1.0-2.0) for dietary GI (P(trend) = 0.02). High intake of staples, especially rice, was positively associated with endometrial cancer. The association with GI was more evident among lean and normal weight women, although the test for interaction was not significant. This study suggests that intake of high GL or GI foods, but not carbohydrates per se, may increase risk for endometrial cancer.
- Published
- 2014
3. Fruit, Vegetable, and Animal Food Intake and Breast Cancer Risk by Hormone Receptor Status
- Author
-
Ping-Ping Bao, Hui Cai, Yinghao Su, Kai Gu, Zhi-Xian Ruan, Yu-Tang Gao, Ying Zheng, Xiao-Ou Shu, Wei Zheng, and Wei Lu
- Subjects
Adult ,China ,Cancer Research ,medicine.medical_specialty ,Animal food ,Eggs ,Medicine (miscellaneous) ,Estrogen receptor ,Physiology ,Breast Neoplasms ,Logistic regression ,Article ,Allium ,Eating ,Breast cancer ,Risk Factors ,Surveys and Questionnaires ,Internal medicine ,Fish Products ,Vegetables ,Progesterone receptor ,Odds Ratio ,medicine ,Animals ,Humans ,Aged ,Nutrition and Dietetics ,business.industry ,Case-control study ,Odds ratio ,Middle Aged ,medicine.disease ,Diet ,Meat Products ,Logistic Models ,Milk ,Endocrinology ,Receptors, Estrogen ,Oncology ,Hormone receptor ,Case-Control Studies ,Fruit ,Female ,Receptors, Progesterone ,business - Abstract
The effects of diet on breast cancer are controversial and whether the effects vary with hormone receptor status has not been well investigated. This study evaluated the associations of dietary factors with risk for breast cancer overall and by the hormone receptor status of tumors among Chinese women. The Shanghai Breast Cancer Study, a large, population-based, case-control study, enrolled 3,443 cases and 3,474 controls in 1996-1998 (phase I) and 2002-2005 (phase II); 2676 cases had estrogen receptor (ER) and progesterone receptor (PR) data. Dietary intake was assessed using a validated, quantitative, food frequency questionnaire. Odds ratios (OR) and 95% confidence intervals (95% CI) were derived from multivariate, polychotomous, unconditional logistic regression models. Total vegetable intake was inversely related to breast cancer risk, with an adjusted OR for the highest quintile of 0.80 (95% CI = 0.67-0.95; P trend = 0.02). Reduced risk was also related to high intake of allium vegetables (P trend = 0.01) and fresh legumes (P trend = 0.0008). High intake of citrus fruits and rosaceae fruits were inversely associated with breast cancer risk (P trend = 0.003 and 0.004, respectively), although no consistent association was seen for total fruit intake. Elevated risk was observed for all types of meat and fish intake (all P trend0.05), whereas intakes of eggs and milk were associated with a decreased risk of breast cancer (both P trend0.05). There was little evidence that associations with dietary intakes varied across the 4 tumor subtypes or between ER+/PR+ and ER-/PR- tumors (P for heterogeneity0.05). Our results suggest that high intake of total vegetables, certain fruits, milk, and eggs may reduce the risk of breast cancer, whereas high consumption of animal-source foods may increase risk. The dietary associations did not appear to vary by ER/PR status.
- Published
- 2012
4. Association of Hormone-Related Characteristics and Breast Cancer Risk by Estrogen Receptor/Progesterone Receptor Status in the Shanghai Breast Cancer Study
- Author
-
Xiao-Ou Shu, Ping-Ping Bao, Ying Zheng, Zhi-Xian Ruan, Wei Zheng, Wei Lu, Yinghao Su, Kai Gu, Yu-Tang Gao, Sandra L. Deming, and Hui Cai
- Subjects
Adult ,Oncology ,China ,medicine.medical_specialty ,Urban Population ,Epidemiology ,Original Contributions ,medicine.medical_treatment ,Population ,Estrogen receptor ,Breast Neoplasms ,Risk Assessment ,Body Mass Index ,Young Adult ,Breast cancer ,Risk Factors ,Internal medicine ,Biomarkers, Tumor ,medicine ,Humans ,education ,Aged ,Retrospective Studies ,Gynecology ,education.field_of_study ,business.industry ,Age Factors ,Hormone replacement therapy (menopause) ,Odds ratio ,Middle Aged ,Progesterone Receptor Status ,medicine.disease ,Menopause ,Receptors, Estrogen ,Female ,Receptors, Progesterone ,business ,Breast feeding ,Follow-Up Studies - Abstract
Etiologic differences between subtypes of breast cancer defined by estrogen receptor (ER) and progesterone receptor (PR) status are not well understood. The authors evaluated associations of hormone-related factors with breast cancer subtypes in a population-based case-control study involving 1,409 ER-positive (ER+)/PR-positive (PR+) cases, 712 ER-negative (ER-)/PR-negative (PR-) cases, 301 ER+/PR- cases, 254 ER-/PR+ cases, and 3,474 controls aged 20-70 years in Shanghai, China (phase I, 1996-1998; phase II, 2002-2005). Polytomous logistic regression and Wald tests for heterogeneity across subtypes were conducted. Breast cancer risks associated with age at menarche, age at menopause, breastfeeding, age at first livebirth, waist-to-hip ratio, and oral contraceptive use did not differ by hormone receptor status. Among postmenopausal women, higher parity (≥2 children vs. 1) was associated with reduced risk (odds ratio (OR) = 0.69, 95% confidence interval (CI): 0.52, 0.91) and higher body mass index (BMI; weight (kg)/height (m)(2)) with increased risk (highest quartile: OR = 2.40, 95% CI: 1.65, 3.47) of the ER+/PR+ subtype but was unrelated to the ER-/PR- subtype (for parity, P(heterogeneity) = 0.02; for BMI, P(heterogeneity) < 0.01). Hormone replacement therapy (OR = 2.25, 95% CI: 1.40, 3.62) and alcohol consumption (OR = 1.59, 95% CI: 1.01, 2.51) appeared to be preferentially associated with the ER+/PR- subtype. These findings indicate that BMI, parity, hormone replacement therapy, and alcohol consumption may play different roles in subtypes of breast cancer. More research is needed to better understand the etiology of 2 relatively rare subtypes, ER+/PR- tumors and ER-/PR+ tumors.
- Published
- 2011
5. Dietary Iron Intake and Risk of Endometrial Cancer: A Population-Based Case-Control Study in Shanghai, China
- Author
-
Sang Ah Lee, Wanghong Xu, Yu-Tang Gao, Hui Cai, Asha R. Kallianpur, Xiao-Ou Shu, Wei Zheng, Zhi Xian Ruan, and Yong-Bing Xiang
- Subjects
Adult ,China ,Cancer Research ,medicine.medical_specialty ,Meat ,Medicine (miscellaneous) ,Physiology ,Heme ,Article ,Body Mass Index ,Risk Factors ,Internal medicine ,Odds Ratio ,Animals ,Humans ,Medicine ,Obesity ,Risk factor ,Aged ,Nutrition and Dietetics ,business.industry ,Endometrial cancer ,Age Factors ,Case-control study ,Odds ratio ,Middle Aged ,medicine.disease ,Dietary Fats ,Diet Records ,Diet ,Endometrial Neoplasms ,Postmenopause ,Menopause ,Logistic Models ,Endocrinology ,Oncology ,Case-Control Studies ,Red meat ,Female ,business ,Body mass index ,Iron, Dietary - Abstract
Dietary red meat and animal fat have been linked to endometrial cancer (EC) risk, but the impact of bioavailable iron in animal-derived foods has been less well studied. Our objective was to investigate the effects of iron and fats on the risk of EC in a large, population-based, case-control study. The Shanghai Endometrial Cancer Study enrolled 1,204 EC cases and 1,212 controls who completed in-person interviews, including a food frequency questionnaire. Animal-derived iron and fat intakes were calculated from dietary intakes and food composition tables. Logistic regression models were used to evaluate independent and joint effects of iron and fat on EC risk. Animal-derived iron intake was positively associated with EC risk [adjusted OR = 1.9; 95% CI = 1.4–2.7, Ptrend < 0.01, highest vs. lowest quartile], predominantly after menopause (OR = 2.2; 95%CI = 1.4–3.4, Ptrend < 0.01) and in women with BMI ≥ 25 kg/m2(OR = 3.2; 95% CI = 1.4–7.5 in postmenopausal obese women, Ptrend < 0.01). Animal-derived fat was also associated with postmenopausal EC risk (OR = 1.7; 95% CI = 1.2–2.5, Ptrend < 0.01). Multiplicative interactions between animal-derived iron and BMI or animal-derived fat intake were not observed. Animal-derived iron intake is associated with increased risk of EC after menopause and among obese women. Avoidance of animal-derived (heme) iron may reduce the risk of EC in these women.
- Published
- 2009
6. Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population
- Author
-
Xiao-Ou Shu, Wanghong Xu, Yong-Bing Xiang, Jia-Rong Cheng, Qiuyin Cai, Zhi-Xian Ruan, Wei Zheng, and Jirong Long
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Population ,Single-nucleotide polymorphism ,Biology ,Polymorphism, Single Nucleotide ,Linkage Disequilibrium ,Article ,Asian People ,Risk Factors ,Internal medicine ,Genotype ,medicine ,Humans ,Genetic Predisposition to Disease ,Risk factor ,education ,Genetics ,education.field_of_study ,Endometrial cancer ,Haplotype ,Cancer ,Odds ratio ,Middle Aged ,medicine.disease ,Endometrial Neoplasms ,Haplotypes ,Female ,Receptors, Progesterone - Abstract
BACKGROUND: Single nucleotide polymorphisms (SNPs) in the progesterone receptor (PGR) gene have been associated with the risk of endometrial cancer. However, to the authors' knowledge, no study to date has systematically evaluated the role of the PGR gene in endometrial carcinogenesis. METHODS: Exposure information and DNA samples collected in the Shanghai Endometrial Cancer Study, a population-based case-control study of 1204 incident cases and 1212 age- and frequency-matched population controls, were used in this study. Seven tag SNPs were identified for the PGR gene plus the 5-kilobase (kb) flanking regions using the Han Chinese data from the HapMap project with a pairwise correlation coefficient (r2) ≥ 0.90. These 7 SNPs captured 92% of SNPs in the region with a pairwise r2 ≥ 0.90 or 100% of SNPs with a pairwise r2 ≥ 0.80. Genotyping of polymorphisms was performed by using the Affymetrix MegAllele Targeted Genotyping System. A logistic regression model was used to compute adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs). RESULTS: Of 7 tag SNPs that were assessed, 2 polymorphisms in the 3′ flanking region of the PGR gene, reference SNP identification number (rs) 11224561 (rs11224561) and rs471767, were associated with the risk of endometrial cancer. The cytosine/cytosine (CC) genotype of SNP rs11224561 was associated with decreased risk (OR, 0.68; 95% CI, 0.50-0.92) compared with the thymine/thymine (TT) genotype. Carrying the guanine (G) allele of the rs471767 SNP also was associated with decreased risk, although the association was not statistically significant (OR, 0.78, 95%CI, 0.59-1.04 and OR, 0.32, 95%CI, 0.03-3.05 for the adenine [A]G and GG genotypes, respectively, compared with the homozygote AA). CONCLUSIONS: The current findings suggested that polymorphisms in the 3′ flanking region of the PGR gene may be associated with the risk of endometrial cancer. Cancer 2009. © 2009 American Cancer Society.
- Published
- 2009
7. Common MMP-7 Polymorphisms and Breast Cancer Susceptibility: A Multistage Study of Association and Functionality
- Author
-
Qiuyin Cai, Sandra L. Deming, Wei Zheng, Jirong Long, Yu-Tang Gao, Xiao-Ou Shu, Ying Zheng, Jay Snoddy, Shimian Qu, Shawn Levy, Alicia Beeghly-Fadiel, Zhi-Xian Ruan, Chun Li, and Wei Lu
- Subjects
Adult ,Cancer Research ,Breast Neoplasms ,Electrophoretic Mobility Shift Assay ,Single-nucleotide polymorphism ,Biology ,Polymorphism, Single Nucleotide ,Article ,Metastasis ,Breast cancer ,medicine ,Humans ,SNP ,Genetic Predisposition to Disease ,Allele ,Genotyping ,DNA Primers ,Genetics ,Base Sequence ,Case-control study ,Proteolytic enzymes ,Middle Aged ,medicine.disease ,Oncology ,Case-Control Studies ,Matrix Metalloproteinase 7 ,Female - Abstract
Matrix metalloproteinase-7 (MMP-7) is a small secreted proteolytic enzyme with broad substrate specificity against ECM and non-ECM components. Known to be vital for tumor invasion and metastasis, accumulating evidence also implicates MMP-7 in cancer development. Using data from the Shanghai Breast Cancer Study, we conducted a two-stage study to evaluate the association of MMP-7 single nucleotide polymorphisms (SNPs) with breast cancer risk. Additionally, associated SNPs were characterized by laboratory assays. In stage 1, 11 SNPs were genotyped among 1,079 incident cases and 1,082 community controls using an Affymetrix Genotyping System. Promising SNPs were selected for stage 2 evaluation and genotyped by TaqMan allelic discrimination assays in an independent set of 1,911 cases and 1,811 controls. Three SNPs were selected for stage 2 validation (rs880197, rs10895304, and rs12184413); one had highly consistent results between the two stages of the study. In combined analysis, homozygosity for the variant T allele for rs12184413 was associated with an odds ratio (OR) of 0.7 [95% confidence interval (95% CI), 0.6–0.9] compared with the common C allele. This effect was slightly more pronounced in postmenopausal women (OR, 0.6; 95% CI, 0.4–0.8) than in premenopausal women (OR, 0.8; 95% CI, 0.6–1.1). This SNP is located 3′ of the MMP-7 gene, in an area enriched with CTCF binding sites. In silico analysis suggested a regulatory role for this region, and our in vitro assays showed an allelic difference in nuclear protein binding capacity. Results from our study suggest that common MMP-7 genetic polymorphisms may contribute to breast cancer susceptibility. [Cancer Res 2008;68(15):6453–9]
- Published
- 2008
8. UGT1A1 Genetic Polymorphisms, Endogenous Estrogen Exposure, Soy Food Intake, and Endometrial Cancer Risk
- Author
-
Yong-Bing Xiang, Wei Zheng, Sandra L. Deming, Qiuyin Cai, Xiao-Ou Shu, Zhi-Xian Ruan, and Wanghong Xu
- Subjects
medicine.medical_specialty ,Genotype ,Epidemiology ,medicine.drug_class ,Population ,Biology ,Body Mass Index ,Interviews as Topic ,Risk Factors ,Internal medicine ,medicine ,Humans ,Glucuronosyltransferase ,education ,education.field_of_study ,Chi-Square Distribution ,Polymorphism, Genetic ,Endometrial cancer ,Case-control study ,Soy Foods ,Cancer ,Estrogens ,Odds ratio ,Middle Aged ,medicine.disease ,Endometrial Neoplasms ,Logistic Models ,Endocrinology ,Oncology ,Estrogen ,Case-Control Studies ,Female ,Body mass index ,Contraceptives, Oral - Abstract
Estrogen exposures play a critical role in the development of endometrial cancer. Genetic variation in the estrogen metabolism UGT1A1 gene may modify the effect of estrogenic exposures on endometrial cancer risk. We tested this hypothesis in a population-based case-control study of 1,047 endometrial cancer cases and 1,035 controls who completed an in-person interview and were genotyped for the UGT1A1 polymorphisms rs2070959 (A/G), rs887829 (G/A), and rs8175347 (6/7 TA repeats). Estrogen exposure-related factors evaluated include menstrual characteristics, oral contraceptive use, body mass index, waist-hip ratio, and soy food intake. Conditional logistic regression was used to calculate odds ratios and 95% confidence intervals. The homozygote variant genotype (G/G) of the rs2070959 polymorphism was significantly associated with a reduced risk of endometrial cancer (odds ratio, 0.5; 95% confidence interval, 0.3-0.8). No significant associations between endometrial cancer risk and genotype were seen for the rs887829 and rs8175347 polymorphisms. Analysis of the joint effects of genotype and markers of estrogen exposure found the lowest risk of endometrial cancer among those with the homozygous variant genotype of the rs2070959 polymorphism and who were postmenopausal, had low body mass index, and had low soy food intake, although a test for multiplicative interaction was not significant. Taken together, these data suggest that the G/G genotype (rs2070959) in the UGT1A1 gene may decrease the risk of endometrial cancer and that this effect is most evident among women with low levels of endogenous estrogen exposure or with low soy food intake. (Cancer Epidemiol Biomarkers Prev 2008;17(3):563–70)
- Published
- 2008
9. The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk
- Author
-
Wanqing Wen, Jia-Rong Cheng, Zhi Xian Ruan, Yong-Bing Xiang, Xiao-Ou Shu, Qiuyin Cai, Wanghong Xu, and Wei Zheng
- Subjects
Adult ,China ,Cancer Research ,medicine.medical_specialty ,Polymorphism, Single Nucleotide ,Article ,Body Mass Index ,Insulin resistance ,Waist–hip ratio ,Risk Factors ,Internal medicine ,medicine ,Humans ,Obesity ,Risk factor ,Aged ,Biologic marker ,Waist-Hip Ratio ,business.industry ,Endometrial cancer ,Cancer ,Middle Aged ,medicine.disease ,Endometrial Neoplasms ,C-Reactive Protein ,Endocrinology ,Haplotypes ,Premenopause ,Oncology ,Case-Control Studies ,Chromosomal region ,Female ,Insulin Resistance ,business - Abstract
Obesity has been established as a major risk factor for endometrial cancer. Previous studies have suggested that the mechanism behind this increased risk for endometrial cancer may be due to the estrogenic effects associated with obesity. However, it has recently been hypothesized that other mechanisms, in particular, obesity-related insulin resistance and inflammation(1;2), may also contribute to the association of endometrial cancer with obesity. Obesity, particularly central obesity, is considered a systemic inflammatory condition and is strongly related to insulin resistance(3;4). Two recent studies(5;6) and several previous ones(7–10) have suggested that central obesity is a more important predictor of endometrial cancer risk than general obesity. C-reactive protein (CRP) is the most recognized biologic marker of chronic systematic inflammation(11;12). CRP levels are correlated with obesity and insulin resistance. Polymorphisms in the CRP gene have been associated with CRP levels(13–17). It is of interest that the CRP gene is located on chromosome 1q21-q23, the same general chromosomal region as the type 2 diabetes mellitus susceptibility locus. Studies have shown that CRP gene variations may influence insulin sensitivity(18;19). Therefore, it is conceivable that the CRP gene might work in concert with obesity-related insulin resistance and inflammation in the development of endometrial cancer. We previously reported(20) that endometrial cancer was significantly associated with central obesity as measured by waist-to-hip ratio (WHR) and waist circumference, and the positive association with general obesity as measured with body mass index (BMI) vanished after adjusting for central obesity. In this study with an expanded sample size, we evaluate the role of CRP gene polymorphisms in endometrial cancer risk with an emphasis on investigating the modifying effect of CRP gene polymorphisms on the association between central obesity and endometrial cancer risk.
- Published
- 2008
10. Interaction of Soy Food and Tea Consumption with CYP19A1 Genetic Polymorphisms in the Development of Endometrial Cancer
- Author
-
Qi Dai, Jirong Long, Xiao-Ou Shu, Yong-Bing Xiang, Wanghong Xu, Zhi Xian Ruan, Wei Zheng, and Jia Rong Cheng
- Subjects
China ,medicine.medical_specialty ,Epidemiology ,Population ,Physiology ,Single-nucleotide polymorphism ,Article ,Aromatase ,Risk Factors ,Surveys and Questionnaires ,Internal medicine ,Odds Ratio ,medicine ,Humans ,Registries ,education ,Alleles ,education.field_of_study ,Polymorphism, Genetic ,Tea ,biology ,business.industry ,Endometrial cancer ,Case-control study ,Soy Foods ,Cancer ,Odds ratio ,Middle Aged ,medicine.disease ,Confidence interval ,Endometrial Neoplasms ,Endocrinology ,Haplotypes ,Case-Control Studies ,biology.protein ,Female ,business - Abstract
Certain polyphenols inhibit the activity of aromatase, a critical enzyme in estrogen synthesis that is coded by the CYP19A1 gene. Consumption of polyphenol-rich foods and beverages, thus, may interact with CYP19A1 genetic polymorphisms in the development of endometrial cancer. The authors tested this hypothesis in the Shanghai Endometrial Cancer Study (1997-2003), a population-based case-control study of 1,204 endometrial cancer cases and 1,212 controls. Dietary information was obtained by use of a validated food frequency questionnaire. Genotypes of CYP19A1 at rs28566535, rs1065779, rs752760, rs700519, and rs1870050 were available for 1,042 cases and 1,035 controls. Unconditional logistic regression models were used to calculate odds ratios and their 95% confidence intervals after adjustment for potential confounding factors. Higher intake of soy foods and tea consumption were both inversely associated with the risk of endometrial cancer, with odds ratios of 0.8 (95% confidence interval: 0.6, 1.0) for the highest versus the lowest tertiles of intake of soy and 0.8 (95% confidence interval: 06, 0.9) for ever tea consumption. The association of single nucleotide polymorphisms rs1065779, rs752760, and rs1870050 with endometrial cancer was modified by tea consumption (p(interaction) < 0.05) but not by soy isoflavone intake. The authors' findings suggest that tea polyphenols may modify the effect of CYP19A1 genetic polymorphisms on the development of endometrial cancer.
- Published
- 2007
11. Functional Plasminogen Activator Inhibitor-1 Gene Variants and Breast Cancer Survival
- Author
-
Yu-Tang Gao, Wei Zheng, Zhi-Xian Ruan, Xianglan Zhang, Xiao-Ou Shu, and Qiuyin Cai
- Subjects
Genetic Markers ,Oncology ,China ,Cancer Research ,medicine.medical_specialty ,Population ,Breast Neoplasms ,Metastasis ,chemistry.chemical_compound ,Breast cancer ,Internal medicine ,Plasminogen Activator Inhibitor 1 ,Genotype ,medicine ,Humans ,Neoplasm Invasiveness ,Registries ,Neoplasm Metastasis ,education ,education.field_of_study ,business.industry ,Proportional hazards model ,Hazard ratio ,Genetic Variation ,Cancer ,Prognosis ,medicine.disease ,Survival Analysis ,chemistry ,Plasminogen activator inhibitor-1 ,Immunology ,Female ,business - Abstract
Purpose: Plasminogen activator inhibitor-1 (PAI-1) plays an important role in cancer invasion and metastasis. A common polymorphism (4G/5G) in the promoter region of the PAI-1 gene has been reported to influence transcription and plasma levels of PAI-1. We evaluated the association between PAI-1 4G/5G polymorphism and breast cancer survival in a population-based cohort of breast cancer patients. Experimental Design: Included in this analysis were 1,083 Chinese women diagnosed with stage 0 to III primary breast cancer at age 25 to 64 years who were recruited between 1996 and 1998 for the Shanghai Breast Cancer Study and followed for a median of 5.2 years. The Kaplan-Meier method and Cox model were used to evaluate the genotype and survival association. Results: After adjustment for known prognostic factors for breast cancer, patients homozygous for the 4G allele had significantly poorer disease-free survival [hazard ratio (HR), 1.7; 95% confidence interval (95% CI), 1.1-2.4] and overall survival (HR, 1.5; 95% CI, 1.0-2.3) than those homozygous for the 5G allele. The association was more evident in patients with advanced disease. The HRs (95% CI) were 3.5 (1.4-9.0) for disease-free survival and 3.1 (1.1-8.3) for overall survival in stage III patients. Conclusions: The PAI-1 4G/5G polymorphism may be a prognostic marker for young and middle-aged Chinese breast cancer patients.
- Published
- 2006
12. Oral contraceptive and IUD use and endometrial cancer: A population-based case-control study in Shanghai, China
- Author
-
Yu-Tang Gao, Meng-Hua Tao, Jing Gao, Zhi Xian Ruan, Xiao-Ou Shu, Yong-Bing Xiang, Wanghong Xu, Wei Zheng, Zuo-Feng Zhang, and Jia Rong Cheng
- Subjects
Gynecology ,Cancer Research ,medicine.medical_specialty ,education.field_of_study ,business.industry ,Endometrial cancer ,Population ,Case-control study ,Cancer ,Odds ratio ,medicine.disease ,Intrauterine device ,Oncology ,medicine ,Population study ,Risk factor ,business ,education - Abstract
Oral contraceptive (OC) and intrauterine device (IUD) use have been shown to be protective factors for endometrial cancer in several epidemiological studies; however, few studies have been conducted in Chinese populations. We evaluated the association between OC and IUD use and endometrial cancer risk in a population-based case-control study among Chinese women in Shanghai, China. The study included 1,204 newly diagnosed endometrial cancer cases and 1,212 age frequency-matched healthy controls. Logistic regression models were used to estimate adjusted odds ratios (OR) and their 95% confidence intervals (95% CI). In our study population, 18.5% cases and 24.9% controls reported having ever used OCs with an OR of 0.75 (95% CI, 0.60-0.93), after adjusting for known risk or protective factors for endometrial cancer. The risk of endometrial cancer decreased with long-term use of OCs with the OR for more than 72 months of use being 0.50 (95% CI, 0.30-0.85). The effect of OC use remained 25 or more years after cessation of use; the associated OR was 0.57 (95% CI = 0.42-0.78) as compared to nonusers. Similarly, fewer cases than controls had ever used IUD, with the multivariable adjusted OR being 0.53 (95% CI = 0.43-0.65). A reduction in risk was observed regardless the duration of use or age at first and last use. These results suggest that OC and IUD use may confer long-term protection against endometrial cancer.
- Published
- 2006
13. Association of Overweight with Breast Cancer Survival
- Author
-
Zhi Xian Ruan, Wei Zheng, Xiao-Ou Shu, Yu-Tang Gao, and Meng-Hua Tao
- Subjects
Adult ,China ,medicine.medical_specialty ,Epidemiology ,Breast Neoplasms ,Overweight ,Body Mass Index ,Waist–hip ratio ,Breast cancer ,Risk Factors ,Internal medicine ,medicine ,Humans ,Registries ,Survival analysis ,Proportional Hazards Models ,business.industry ,Proportional hazards model ,Cancer ,Middle Aged ,Prognosis ,medicine.disease ,Survival Analysis ,Body Height ,Surgery ,Cohort ,Female ,medicine.symptom ,business ,Body mass index - Abstract
The authors investigated the association between overweight at the time of or soon after cancer diagnosis and survival in a cohort of 1,455 breast cancer patients aged 25-64 years. The patients were recruited into the Shanghai Breast Cancer Study (Shanghai, China), a population-based case-control study, between August 1996 and March 1998. The median follow-up time for this cohort was 5.1 years (1996-2002) after breast cancer diagnosis, and 240 deaths were identified. Being overweight at cancer diagnosis or soon afterward, as measured by body mass index (BMI; weight (kg)/height (m)(2)), was associated with poorer overall survival and disease-free survival. Five-year survival rates were 86.5%, 83.8%, and 80.1% for subjects whose BMIs were23.0, 23.0-24.9, andor=25.0, respectively (p = 0.02); the corresponding 5-year disease-free survival rates were 81.9%, 78.1%, and 76.6% (p = 0.05). The inverse association between BMI and survival persisted after adjustment for age at diagnosis and other known prognostic factors for breast cancer, including disease stage. The authors found neither waist:hip ratio nor waist circumference to be independently associated with overall survival or disease-free survival. These results suggest that excess weight may be an independent predictor of breast cancer survival among Chinese women.
- Published
- 2005
14. Weight history and risk of endometrial cancer among Chinese women
- Author
-
Jia Rong Cheng, Xianglan Zhang, Yu-Tang Gao, Zhi Xian Ruan, Xiao-Ou Shu, Wei Zheng, Yong-Bing Xiang, and Wanghong Xu
- Subjects
Gynecology ,medicine.medical_specialty ,education.field_of_study ,Epidemiology ,Obstetrics ,business.industry ,Endometrial cancer ,Weight change ,Population ,Cancer ,General Medicine ,Odds ratio ,medicine.disease ,Menopause ,medicine ,Risk factor ,business ,education ,Body mass index - Abstract
Adult obesity is a well-established risk factor for endometrial cancer. However little is known about the association of endometrial cancer risk with body size early in life and weight change during adulthood. We investigated whether women with greater early-age body size or with greater weight change during adulthood have an increased risk of endometrial cancer. We analysed data from a population-based case-control study of endometrial cancer conducted between 1997 and 2001 in Shanghai China. Included in this analysis were 832 endometrial cancer cases aged 30-69 years and 846 population controls. Information on weight and height history from adolescence through adulthood was obtained via structured in-person interviews. A logistic regression model was used to derive odds ratios (ORs) and 95% confidence intervals (CIs) for endometrial cancer in association with adolescent and adult adiposity as well as adult body weight change. All ORs were adjusted for age education menstrual status duration of menstruation number of pregnancies oral contraceptive use and family history of cancer. Perceived weights and heights during puberty that were greater than average were associated with a modestly increased risk of cancer. The association for perceived weight was substantially weakened after adjustment for current body mass index (BMI). High BMI at all adult ages significantly predicted endometrial cancer risk with recent BMI being the strongest predictor. Further analyses disclosed that weight gain during adulthood particularly during the peri-menopausal period (age 40-50 years) was associated with a significantly elevated risk of endometrial cancer even among currently non-obese women. Gaining > 5 kg between age 40 and 50 was related to ORs of 2.3 (95% CI 1.4-3.9) for women with a BMI 25 kg/m2 and 2.0 (95% CI 1.3-3.0) for women with BMI = 25 kg/m2. Adult weight gain particularly during the peri-menopausal period plays a significant role in the development of endometrial cancer risk. (authors)
- Published
- 2005
15. Effect of Adiposity and Fat Distribution on Endometrial Cancer Risk in Shanghai Women
- Author
-
Zhi Xian Ruan, Yu-Tang Gao, Wanghong Xu, Jia Rong Cheng, Xiao-Ou Shu, Charles E. Matthews, Wei Zheng, and Yong-Bing Xiang
- Subjects
Adult ,China ,medicine.medical_specialty ,Waist ,Epidemiology ,Health Behavior ,Population ,Comorbidity ,Age Distribution ,Waist–hip ratio ,Risk Factors ,Internal medicine ,Odds Ratio ,medicine ,Body Size ,Humans ,Obesity ,Risk factor ,education ,Life Style ,Aged ,Waist-to-height ratio ,education.field_of_study ,Body volume index ,Obstetrics ,business.industry ,nutritional and metabolic diseases ,Odds ratio ,Middle Aged ,Endometrial Neoplasms ,Causality ,Endocrinology ,Adipose Tissue ,Socioeconomic Factors ,Case-Control Studies ,Body Composition ,Female ,business ,Body mass index ,Contraceptives, Oral - Abstract
The authors conducted a population-based case-control study of 832 endometrial cancer cases and 846 frequency-matched controls in Shanghai, China (1997-2001), to examine the association of overall adiposity and body fat distribution with disease risk. Overall adiposity was estimated using weight and body mass index (BMI); upper body fat distribution was evaluated using waist circumference and waist:hip ratio. Overall and upper-body obesity were both associated with an elevated risk of endometrial cancer. Adjusted odds ratios and 95% confidence intervals for highest-versus-lowest quartile comparisons were 2.6 (95% confidence interval (CI): 2.0, 3.5) for weight, 2.9 (95% CI: 2.2, 3.9) for BMI, 4.7 (95% CI: 3.4, 6.4) for waist circumference, and 3.5 (95% CI: 2.6, 4.8) for waist:hip ratio. The positive associations with weight and BMI vanished after results were controlled for waist circumference, while associations with waist circumference and waist:hip ratio persisted after adjustment for BMI. The positive association with upper-body obesity was more pronounced among younger women, women who had never used oral contraceptives, and women with a history of diabetes mellitus (p for multiplicative interaction < 0.05). Upper-body obesity was related to increased risk among women with low BMI. These results suggest that obesity, particularly upper-body fat deposition, is associated with an increased risk of endometrial cancer.
- Published
- 2005
16. MTHFR genotypes and breast cancer survival after surgery and chemotherapy: a report from the Shanghai Breast Cancer Study
- Author
-
Hui Cai, Martha J. Shrubsole, Zhi Xian Ruan, Wei Zheng, Yu-Tang Gao, Qi Niu, Qiuyin Cai, and Xiao-Ou Shu
- Subjects
Adult ,China ,Cancer Research ,medicine.medical_specialty ,Genotype ,Breast Neoplasms ,Cohort Studies ,Breast cancer ,Predictive Value of Tests ,Risk Factors ,medicine ,Humans ,Methylenetetrahydrofolate Reductase (NADPH2) ,Survival analysis ,Neoplasm Staging ,Polymorphism, Genetic ,biology ,Proportional hazards model ,business.industry ,Hazard ratio ,Cancer ,Middle Aged ,medicine.disease ,Survival Analysis ,Surgery ,Oncology ,Methylenetetrahydrofolate reductase ,Cohort ,biology.protein ,Female ,business - Abstract
Methylenetetrahydrofolate reductase (MTHFR) regulates the intracellular folates pool for DNA synthesis and methylation. Sequence variations in MTHFR (nucleotides 677 (C--T) and 1298 (A--C)) result in allozymes with decreased activity. The 677TT genotype is associated with increased toxicity of methotrexate and increased clinical response to 5-fluorouracil in treatment of cancers including breast cancer. We evaluated MTHFR genotypes and breast cancer survival in a cohort of 1067 Chinese women diagnosed with breast cancer between 1996 and 1998 who received surgery and chemotherapy. Life table method was used to calculate 5-year survival rates. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) after adjusting for potential confounding factors. Median follow-up time was 5.2 years; 5-year survival was 84.6%. Sixty-six percent carried a 677T allele and 31% carried a 1298 C allele. We found that overall 5-year breast cancer survival did not differ significantly across all genotypes (85.3% for 677 CC and 83.8% for 677TT; 83.8% for 1298 AA and 79.1% for 1298 CC). However, carrying the 677T allele was associated with non-significant increased risk of death for subjects with late stage disease (stages III-IV) (HR=1.80, 95% CI: 0.79-4.14 for TT vs. CC, p for trend=0.15), particularly among those who had survived past the second year (HR=2.97, 95% CI: 1.10-7.98, p for trend=0.04). The A1298C genotypes were not significantly associated with risk of death. This study suggests that the MTHFR C677T polymorphisms may affect long-term survival from advanced breast cancer.
- Published
- 2005
17. Physical Activity and Risk of Endometrial Cancer: A Report from the Shanghai Endometrial Cancer Study
- Author
-
Yu-Tang Gao, Xiao-Ou Shu, Charles E. Matthews, Zhi Xian Ruan, Wei Zheng, Jia Rong Cheng, Wanghong Xu, and Yong-Bing Xiang
- Subjects
Adult ,China ,medicine.medical_specialty ,Adolescent ,Epidemiology ,Population ,Physical exercise ,medicine ,Humans ,Risk factor ,education ,Exercise ,Life Style ,Aged ,Gynecology ,education.field_of_study ,business.industry ,Endometrial cancer ,Case-control study ,Odds ratio ,Middle Aged ,medicine.disease ,Confidence interval ,Endometrial Neoplasms ,Logistic Models ,Social Class ,Oncology ,Case-Control Studies ,Female ,Energy Metabolism ,business ,Demography - Abstract
We evaluated the type and amount of physical activity associated with risk of endometrial cancer. In this population-based case-control study, in-person interviews were completed among 832 incident endometrial cancer cases and 846 age-matched controls. Physical activity from exercise, household activities, and transportation was assessed in adolescence and adulthood, as was lifetime occupational activity. Logistic regression was used to estimate adjusted odds ratios (OR) and 95% confidence limits (95% CL). Women reporting exercise participation in both adolescence and adulthood were at nearly a 40% reduced risk (OR, 0.63; 95% CL, 0.42-0.95), compared with women reporting no exercise in either life period. Postmenopausal women who initiated exercise in adulthood were also at reduced risk (OR, 0.76; 95% CL, 0.56-1.02). Reductions in risk were also observed for common lifestyle activities, including household activity (both life periods) and walking for transportation (adulthood). Examination of the independent and combined effect of exercise and lifestyle activities revealed that women with less active lifestyles but who reported exercise were at 35% reduced risk (OR, 0.65; 95% CL, 0.41-1.02), whereas nonexercisers with more active lifestyles were at 40% to 45% reduced risk. These findings suggest that both lifestyle activities of lower intensity (e.g., walking and doing household chores) and intentional exercise can reduce endometrial cancer risk.
- Published
- 2005
18. Polymorphisms in ER-α Gene Interact with Estrogen Receptor Status in Breast Cancer Survival
- Author
-
Sonia M. Boyapati, Xiao Ou Shu, Zhi Xian Ruan, Qiuyin Cai, Jeffrey R. Smith, Wanqing Wen, Yu-Tang Gao, and Wei Zheng
- Subjects
Cancer Research ,Oncology - Abstract
Purpose: The effects of estrogens are mediated primarily through estrogen receptor (ER) in breast tissue, and polymorphisms in the ER genes may alter the functions of these receptors. Polymorphisms in the ER-α gene have been reported to be associated with breast cancer risk. However, to our knowledge, no study has been published on the relation between ER-α gene polymorphisms and breast cancer survival. Experimental Design: To determine whether three common polymorphisms in the ER-α gene, PvuII, XbaI, and GT dinucleotide repeats are associated with breast cancer survival, we evaluated data from a cohort of 1,069 breast cancer patients who participated in the Shanghai Breast Cancer Study between 1996 and 1998. The median follow-up time for this cohort of women was 5.2 years. Results: No overall association was observed between ER gene polymorphisms and breast cancer survival. The genotype associations, however, were modified by ER status in breast cancer tissues. Comparing those with the PP genotype to the pp genotype of the PvuII polymorphism, the hazard ratios (HR) of dying were 3.30 [95% confidence interval (95% CI), 1.42-7.69] and 0.54 (95% CI, 0.24-1.23), respectively, for participants with ER-negative breast cancer and ER-positive breast cancer. Similarly, compared with those with no (GT)23 alleles, carrying one or two (GT)23 alleles of the GT repeat polymorphism was related to a HR of 1.48 (95% CI, 0.77-2.87) for ER-negative breast cancer and a HR of 0.25 (95% CI, 0.09-0.69) for ER-positive cancer. The effect of ER on breast cancer survival was also modified by genotypes of ER-α gene. Tests for multiplicative interaction were highly significant. Conclusions: These data suggest that the ER-α gene polymorphisms and ER status may have an interactive effect on breast cancer survival.
- Published
- 2005
19. The Long-Term Impact of Medical and Socio-Demographic Factors on the Quality of Life of Breast Cancer Survivors Among Chinese Women
- Author
-
Hui Cai, Xiao-Ou Shu, Zhi-Xian Ruan, Wanqing Wen, Yu-Tang Gao, Wei Zheng, Yong Cui, and Fan Jin
- Subjects
Adult ,Gerontology ,China ,Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Population ,Psychological intervention ,Breast Neoplasms ,Disease ,Education ,Breast cancer ,Quality of life ,medicine ,Humans ,Survivors ,education ,Aged ,education.field_of_study ,business.industry ,Public health ,Social Support ,Middle Aged ,medicine.disease ,humanities ,Radiation therapy ,Oncology ,Case-Control Studies ,Income ,Quality of Life ,Marital status ,Female ,Neoplasm Recurrence, Local ,business ,Needs Assessment - Abstract
Quality of life (QOL) has become an integral part of the modern assessment of cancer treatment in Western society. However, little is known about the QOL of Chinese breast cancer survivors. To evaluate the long-term impact of medical and socio-demographic factors on survivors' QOL, we conducted a population-based study of 1065 breast cancer survivors in Shanghai, China. The mean age at diagnosis was 48.1 years and the median survival time was 4.3 years for the study participants. The Generic Quality of Life Inventory was used to assess survivors' QOL. Multiple linear regression models were employed to analyze the associations of QOL outcomes with socio-demographic and medical factors. The results revealed that recurrence status, time since diagnosis, marital status, income and education all had an independent, significant association with overall QOL and differential domains of QOL. Age at diagnosis exhibited a dual effect on QOL, positively associated with material well-being and negatively associated with physical well-being. Stage of disease was only associated with social well-being, while the type of surgery was related to material well-being alone. No associations between QOL and chemotherapy or radiotherapy were found. Further, analyses by survival intervals suggested a domain-specific order of recovery of QOL after cancer treatment. These results fill gaps in the limited literature, and provide valuable information for physicians to target the specific needs of Chinese women with breast cancer, choose appropriate interventions at the optimal time, and develop strategies accordingly in terms of improvement of patient's QOL.
- Published
- 2004
20. Use of complementary and alternative medicine by Chinese women with breast cancer
- Author
-
Zhi-Xian Ruan, Yu-Tang Gao, Wei Zheng, Fan Jin, Xiao-Ou Shu, Yong Cui, and Wanqing Wen
- Subjects
Adult ,Complementary Therapies ,China ,Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Population ,MEDLINE ,Breast Neoplasms ,Traditional Chinese medicine ,Metastasis ,Breast cancer ,Internal medicine ,medicine ,Acupuncture ,Humans ,education ,Motivation ,education.field_of_study ,Traditional medicine ,business.industry ,Cancer ,Middle Aged ,medicine.disease ,Radiation therapy ,Socioeconomic Factors ,Oncology ,Case-Control Studies ,Female ,business ,Attitude to Health ,Drugs, Chinese Herbal ,Phytotherapy - Abstract
The use of complementary and alternative medicine (CAM) has been rapidly increasing among cancer patients. The aim of this study is to evaluate the prevalence and patterns of CAM use, particularly patients' intentions and their perceived effectiveness of using Chinese herbal medicine (CHM), as well as the relations between the herbal medicine use and demographic and clinical factors among Chinese women with breast cancer. We analyzed the data from a population-based sample of 1065 breast cancer women in urban Shanghai. Patients' average age at diagnosis was 48.1 years and the median time from the initial diagnosis to the follow-up survey was 4.3 years. Overall, 98% of patients had used at least one form of CAM therapy after diagnosis of breast cancer. The most popular CAM modality was traditional Chinese medicine (86.7%), followed by the use of supplements (84.8%), physical exercises (65.5%), and support group attendance (16.6%). CHM was used by 86.4% of patients, while acupuncture was used only by 4.9% of patients. Treating cancer (81.5%) was the most common intentions of using CHM. Other cited intentions included enhancing the immune system (12%), preventing metastasis of cancer or managing other discomforts (7.9%), and lessening menopausal symptoms (4.7%). The majority of patients reported that they had benefited from the use of CHM. Patients who were younger, married, had higher education or income, received chemotherapy or radiotherapy, or had recurrence/metastasis of cancer tended to use CHM more frequently than other patients. The relations between patient characteristics and use of CHMs varied with users' intentions. Given the high prevalence of CAM use among breast cancer patients, research is urgently needed to systematically evaluate the efficacy and safety of CAM use, particularly use of herbal medicines.
- Published
- 2004
21. Genetic Polymorphisms in the TGF- β 1 Gene and Breast Cancer Survival
- Author
-
Hui Cai, Zhi-Xian Ruan, Xiao-Ou Shu, Wei Zheng, Gong Yang, Fan Jin, Yu-Tang Gao, Qiuyin Cai, and Larry Pierce
- Subjects
Genetics ,Oncology ,Cancer Research ,Linkage disequilibrium ,medicine.medical_specialty ,Hazard ratio ,Cancer ,Promoter ,Biology ,medicine.disease ,Breast cancer ,Internal medicine ,Genotype ,medicine ,Allele ,Survival rate - Abstract
The effect of genetic polymorphisms in the TGF-β1 gene at codon 10 (T+29C), codon 25 (G+74C), and the promoter region [C → T at −509 from the transcription site, (C-509T)] on breast cancer survival was evaluated among a cohort of 1111 patients. The median follow-up time for the cohort was 5.17 years after cancer diagnosis. No DNA sequence variation at codon 25 of the TGF-β1 gene was found, whereas polymorphisms in C-509T and T+29C were in strong linkage disequilibrium. Patients who carried the C allele of T+29C polymorphism had a reduced 5-year disease-free survival rate (75.6% for T/C, and 78.2% for C/C) compared with the T/T genotype (85.1%; P, 0.04); the age-adjusted hazard ratio was 1.5 (95% confidence interval, 1.1–2.2). Adjustment for clinical prognostic factors slightly attenuated the association (hazard ratio, 1.4, 95% confidence interval, 1.0–1.9). Our study suggests that genetic polymorphisms in the TGF-β1 gene may play a role in breast cancer progression.
- Published
- 2004
22. Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai
- Author
-
Wanghong Xu, Yong-Bing Xiang, Xiao-Ou Shu, Jia-Rong Cheng, Yu-Tang Gao, Zhi-Xian Ruan, Qi Dai, and Wei Zheng
- Subjects
Adult ,China ,Cancer Research ,medicine.medical_specialty ,media_common.quotation_subject ,Population ,Abortion ,Pregnancy ,Risk Factors ,Odds Ratio ,medicine ,Humans ,education ,Menstrual Cycle ,Menstrual cycle ,Aged ,media_common ,Menarche ,Gynecology ,education.field_of_study ,business.industry ,Obstetrics ,Incidence ,Endometrial cancer ,Odds ratio ,Middle Aged ,medicine.disease ,Endometrial Neoplasms ,Menstruation ,Menopause ,Parity ,Oncology ,Case-Control Studies ,Female ,business - Abstract
The purpose of our study was to evaluate the association of menstrual and reproductive factors with the risk of endometrial cancer. In a population-based case-control study conducted in urban Shanghai, in-person interviews were completed for 833 women aged 30-69 years and an equal number of controls frequency-matched to cases by age. All cases were newly diagnosed with endometrial cancer between January 1, 1997 and December 31, 2001. The unconditional logistic regression model was employed to derive the adjusted odds ratios (ORs) of endometrial cancer and 95% confidence intervals (CIs) in relation to menstrual and reproductive factors. Earlier menarche age, particularly among premenopausal women, and later menopausal age were associated with an elevated risk of endometrial cancer. A clear dose-response relation between endometrial cancer risk and years of menstruation was observed (p for trend < 0.01). Compared to women ever having a pregnancy and women ever having had a live birth, respectively, nulligravity and nulliparity were both associated with a more than one-fold elevated risk of endometrial cancer. Both completed (OR = 3.02, 95% CI 1.10-8.32 for women never having a complete pregnancy) and incomplete pregnancy (OR = 0.69, 95%CI 0.55-0.87) conferred a protective effect against endometrial cancer, and the protective effect appeared to increase with total number of pregnancies (p for trend = 0.01). The effect of pregnancy on endometrial cancer remained unchanged with increasing time since the last pregnancy. Stillbirth and age at first pregnancy was unrelated to endometrial cancer risk. Our study suggests that prolonged menstruation was related to an increased risk of endometrial cancer while pregnancy, including induced abortion, reduced the risk of endometrial cancer.
- Published
- 2003
23. Association of body size and fat distribution with risk of breast cancer among Chinese women
- Author
-
Yu-Tang Gao, Xiao-Ou Shu, Wei Zheng, James R. Hébert, Jian Rong Shi, Fan Jin, John D. Potter, Louise A. Brinton, Qi Dai, and Zhi-Xian Ruan
- Subjects
Adult ,China ,Cancer Research ,medicine.medical_specialty ,Breast Neoplasms ,Overweight ,Weight Gain ,Body Mass Index ,Breast cancer ,Risk Factors ,Odds Ratio ,medicine ,Humans ,Risk factor ,Gynecology ,business.industry ,Body Weight ,Weight change ,Cancer ,Odds ratio ,Middle Aged ,medicine.disease ,Body Height ,Postmenopause ,Adipose Tissue ,Oncology ,Case-Control Studies ,Female ,medicine.symptom ,business ,Body mass index ,Weight gain ,Demography - Abstract
Most previous studies addressing the association of body size, weight change and body fat distribution with the risk of breast cancer were conducted in Western societies with a high proportion of overweight people. It remains unclear whether the dose-response relation observed in earlier studies can be extended to women with “normal” weight based on prevailing Western standards. To address this issue, we analyzed data from a population-based case-control study of breast cancer recently completed among Chinese women in urban Shanghai. In-person interviews and anthropometric measurements were completed for 1,459 women newly diagnosed with breast cancer from 25 to 64 years of age and 1,556 controls frequency-matched to cases on age. Unconditional logistic regression was employed to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CI) related to anthropometric variables and self-reported body weight. Currently measured weight, body mass index [BMI: weight (kg)/height(m)2] or height was each found to be positively related to risk of postmenopausal breast cancer in a dose-response manner, with ORs (95% CI) being 2.0 (1.4–3.0), 2.0 (1.2–3.2) or 1.7 (1.2–2.5), respectively, for the highest category of weight, BMI or height compared to the lowest category of these variables. These variables were unrelated to premenopausal breast cancer risk. Reported weight at ages >40 years and weight gain after age 20 were more predictive for postmenopausal breast cancer than weight at an earlier age. After adjustment for BMI, waist-to-hip ratio was related to an increased risk of premenopausal [OR = 1.7 (1.3–2.3) for the highest category compared to the lowest category] but not postmenopausal breast cancer. This study suggests that, even in a relatively thin Chinese population, weight gain and height are related to an increased risk of postmenopausal breast cancer, while central fat distribution was associated with premenopausal breast cancer. General weight control may be an effective measurement for breast cancer prevention. © 2001 Wiley-Liss, Inc.
- Published
- 2001
24. Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai breast cancer study
- Author
-
Lawrence H. Kushi, Wan-Qing Wen, Louise A. Brinton, Yu-Tang Gao, Roberd M. Bostick, Qi Dai, Wei Zheng, Thomas A. Sellers, Xiao-Ou Shu, John D. Potter, Fan Jin, and Zhi-Xian Ruan
- Subjects
Gynecology ,Cancer Research ,education.field_of_study ,medicine.medical_specialty ,business.industry ,Incidence (epidemiology) ,Population ,Odds ratio ,medicine.disease ,Menopause ,Breast cancer ,Oncology ,Menarche ,Medicine ,Risk factor ,business ,education ,Breast feeding ,Demography - Abstract
The incidence of breast cancer among women in Shanghai, a traditionally low-risk population, has increased substantially over the past 20 years. To evaluate the association of menstrual and reproductive factors with breast cancer risk and the influence of these factors on the temporal trend of breast cancer incidence, we analyzed data from the Shanghai Breast Cancer Study, a population-based case-control study of breast cancer recently completed among Chinese women in urban Shanghai. In-person interviews were completed for 1,459 women newly diagnosed with breast cancer between ages 25 and 64 and for 1,556 controls frequency-matched to cases by age. Unconditional logistic regression was employed to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) related to menstrual and reproductive factors. Earlier menarcheal age, nulliparity, and later age at first live birth were associated with increased risk of breast cancer among both pre- and post-menopausal women, while never having breast-fed and later age at menopause were associated with elevated risk only among post-menopausal women. Among controls, 32% of younger women ( 40 years) reported starting menarche at age of 13 or younger, and this factor contributed to 44% of cases diagnosed among younger women and 26% to 28% of cases in older women. Older age at first live birth or at menopause explained a considerable portion of cases diagnosed in older, but not younger, women. Our study suggests that the changes in menstrual and reproductive patterns among women in Shanghai have contributed to the recent increase in breast cancer incidence, particularly among younger women.
- Published
- 2000
25. Association of thymidylate synthase gene with endometrial cancer risk in a Chinese population
- Author
-
Jirong Long, Genming Zhao, Wei Zheng, Zhi-Xian Ruan, Jia-Rong Cheng, Yong-Bing Xiang, Qiuyin Cai, Wanghong Xu, and Xiao-Ou Shu
- Subjects
Adult ,Risk ,China ,Genotype ,Epidemiology ,Population ,Single-nucleotide polymorphism ,Biology ,Polymorphism, Single Nucleotide ,Article ,medicine ,Humans ,education ,Genotyping ,Aged ,Genetics ,education.field_of_study ,Chi-Square Distribution ,Endometrial cancer ,Incidence ,Haplotype ,Cancer ,Genetic Variation ,Odds ratio ,Thymidylate Synthase ,Middle Aged ,medicine.disease ,Introns ,Endometrial Neoplasms ,Oncology ,Haplotypes ,Case-Control Studies ,Female - Abstract
We comprehensively evaluated genetic variants in the thymidylate synthase (TYMS) gene in association with endometrial cancer risk in a population-based case-control study of 1,199 incident endometrial cancer cases and 1,212 age frequency-matched population controls. Exposure information was obtained via in-person interview, and DNA samples (blood or buccal cell) were collected. Genotyping of 11 haplotype-tagging single nucleotide polymorphisms (SNP) for the TYMS gene plus the 5-kb flanking regions was done for 1,028 cases and 1,003 controls by using the Affymetrix MegAllele Targeted Genotyping System. Of 11 haplotype-tagging SNPs identified, 7 that are located in flanking regions of the TYMS gene are also in the ENOSF1 (rTS) gene. The SNP rs3819102, located in the 3′-flanking region of the TYMS gene and in an intron of the ENOSF1 gene, was associated with risk of endometrial cancer. The odds ratio (95% confidence interval) for the CC genotype was 1.5 (1.0-2.2) compared with the TT genotype. Haplotype TTG in block 2 of the TYMS gene, which includes SNPs rs10502289, rs2298583, and rs2298581 (located in introns of the ENOSF1 gene), was associated with a marginally significant decrease in risk of endometrial cancer under the dominant model (odds ratio, 0.8; 95% confidence interval, 0.6-1.0). This study suggests that genetic polymorphisms in the TYMS or ENOSF1 genes may play a role in the development of endometrial cancer among Chinese women. (Cancer Epidemiol Biomarkers Prev 2009;18(2):579–84)
- Published
- 2009
26. Drinking green tea modestly reduces breast cancer risk
- Author
-
Martha J. Shrubsole, Zhi Xian Ruan, Xiao-Ou Shu, Qiuyin Cai, Ying Zheng, Yu-Tang Gao, Qi Dai, Kai Gu, Zhi Chen, Wei Zheng, and Wei Lu
- Subjects
Adult ,medicine.medical_specialty ,China ,Population ,Medicine (miscellaneous) ,Physiology ,Breast Neoplasms ,Catechol O-Methyltransferase ,complex mixtures ,Animal data ,Breast cancer ,Risk Factors ,Internal medicine ,Medicine ,Humans ,Nutritional Epidemiology ,education ,Aged ,education.field_of_study ,Nutrition and Dietetics ,Tea ,business.industry ,Confounding ,Case-control study ,Cancer ,food and beverages ,Odds ratio ,Middle Aged ,medicine.disease ,Menopause ,Endocrinology ,Case-Control Studies ,business - Abstract
Green tea is a commonly consumed beverage in China. Epidemiological and animal data suggest tea and tea polyphenols may be preventive against various cancers, including breast cancer. Catechol-O-methyltransferase (COMT) catalyzes catechol estrogens and tea polyphenols. The COMT rs4680 AA genotype leads to lower COMT activity, which may affect the relationship between green tea consumption and breast cancer risk. We evaluated whether regular green tea consumption was associated with breast cancer risk among 3454 incident cases and 3474 controls aged 20–74 y in a population-based case-control study conducted in Shanghai, China during 1996–2005. All participants were interviewed in person about green tea consumption habits, including age of initiation, duration of use, brew strength, and quantity of tea. Odds ratios (OR) and 95% CI were calculated for green tea consumption measures and adjusted for age and other confounding factors. Compared with nondrinkers, regular drinking of green tea was associated with a slightly decreased risk for breast cancer (OR, 0.88; 95% CI, 0.79–0.98). Among premenopausal women, reduced risk was observed for years of green tea drinking (P–trend = 0.02) and a dose-response relationship with the amount of tea consumed per month was also observed (P-trend = 0.046). COMT rs4680 genotypes did not have a modifying effect on the association of green tea intake with breast cancer risk. Drinking green tea may be weakly associated with a decreased risk of breast cancer.
- Published
- 2008
27. History of benign breast disease and risk of breast cancer among women in China: a case control study
- Author
-
Zhi-Xian Ruan, Sandra L. Deming, Ying Zheng, Wei Zheng, Yu-Tang Gao, Tsogzolmaa Dorjgochoo, Wei Lu, and Xiao-Ou Shu
- Subjects
Oncology ,Adult ,Cancer Research ,medicine.medical_specialty ,China ,Breast Neoplasms ,Article ,Breast Diseases ,Breast cancer ,Risk Factors ,Internal medicine ,Epidemiology ,medicine ,Humans ,Risk factor ,skin and connective tissue diseases ,Aged ,business.industry ,Public health ,Case-control study ,Middle Aged ,medicine.disease ,Prognosis ,Fibroadenoma ,Clinical trial ,Case-Control Studies ,Female ,Breast disease ,business - Abstract
Data from the Shanghai Breast Cancer Study were analyzed to evaluate the relationship between benign breast disease (BBD) and breast cancer among Chinese women with a self-report of physician-diagnosed BBD.Study participants consisted of 3,452 breast cancer cases and 3,474 population controls recruited by the Shanghai Breast Cancer Study. In-person interviews were conducted to collect information on demographics and suspected risk factors for breast cancer, including a detailed history of BBD. Unconditional logistic regression was used to derive adjusted odds ratios (OR(adj)) and 95% confidence intervals (CI) for the association between self-reported BBD and breast cancer.Women with breast cancer were significantly more likely to have a self-reported history of BBD including lobular proliferation (OR(adj) = 1.6; 95% CI 1.4-1.8), fibroadenoma (OR(adj) = 1.9; 95% CI 1.6-2.3), and other BBD (OR(adj) = 1.6; 95% CI 1.3-2.1). Breast cancer risk was lower for surgically treated fibroadenoma as compared to non-surgically treated and higher for other BBDs that were surgically treated versus non-surgically treated.Our results suggest that personal history of BBD is associated with an increased risk of future breast cancer among women in China. Surgical intervention for fibroadenoma may reduce the risk.
- Published
- 2008
28. Vitamin supplement use and risk for breast cancer: the Shanghai Breast Cancer Study
- Author
-
Xiao-Ou Shu, Martha J. Shrubsole, Qi Dai, Kai Gu, Zhi-Xian Ruan, Wei Zheng, Tsogzolmaa Dorjgochoo, Hui Cai, Wei Lu, Yu-Tang Gao, and Ying Zheng
- Subjects
Oncology ,Vitamin ,Adult ,Risk ,Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Breast Neoplasms ,Ascorbic Acid ,Article ,chemistry.chemical_compound ,Breast cancer ,Internal medicine ,medicine ,Humans ,Vitamin E ,Risk factor ,Vitamin A ,Aged ,Gynecology ,business.industry ,Cancer ,Vitamins ,Middle Aged ,medicine.disease ,B vitamins ,chemistry ,Case-Control Studies ,Dietary Supplements ,Vitamin B Complex ,Female ,Breast disease ,Multivitamin ,business - Abstract
Objective The influence of vitamin supplements on breast cancer risk is unclear and the interactive effects of dietary and supplemental sources are unknown. This study investigated (1) the association between self-reported vitamin supplement use (multivitamin, A, B, C, and E) and breast cancer and (2) the combined effect of vitamin supplements in relation to dietary vitamin intakes on breast cancer risk. Methods The Shanghai Breast Cancer Study was a population-based case-control study conducted in Shanghai in 1996–1998 (Phase I) and 2002–2004 (Phase II). Participants were aged 25–64 (Phase I) and 20–70 years (Phase II). The analyses included 3,454 incident breast cancer cases and 3,474 controls. Unconditional logistic regression models were used to determine adjusted odds ratios (ORs) for breast cancer risk associated with vitamin supplement use. Results Overall, breast cancer risk was not related to any vitamin supplement intake. However, a 20% reduction in breast cancer risk was observed with vitamin E supplement use among women with low-dietary vitamin E intake (OR = 0.8; 95% confidence interval (CI), 0.6–1.0). A non-significant 20% risk reduction was observed among vitamin B supplement users with low B dietary intake (OR = 0.8; 95% CI, 0.6–1.1). Frequent use of a vitamin B supplement was adversely associated with breast cancer risk among those with high dietary vitamin B intake (OR = 1.4; 95% CI: 0.9–2.1; P for interaction = 0.07). Conclusions This study suggests that vitamins E and B supplements may confer protection against breast cancer among women who have low dietary intake of those vitamins.
- Published
- 2007
29. Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women
- Author
-
Wanghong Xu, Yong-Bing Xiang, Qiuyin Cai, Jia-Rong Cheng, Martha J. Shrubsole, Xiao-Ou Shu, Zhi-Xian Ruan, Genming Zhao, and Wei Zheng
- Subjects
Vitamin ,medicine.medical_specialty ,China ,Genotype ,Epidemiology ,Population ,Physiology ,Lower risk ,Polymorphism, Single Nucleotide ,chemistry.chemical_compound ,Folic Acid ,Risk Factors ,Internal medicine ,Surveys and Questionnaires ,medicine ,Humans ,Vitamin B12 ,Registries ,education ,Methylenetetrahydrofolate Reductase (NADPH2) ,education.field_of_study ,Chi-Square Distribution ,Polymorphism, Genetic ,biology ,business.industry ,Endometrial cancer ,Cancer ,Bayes Theorem ,Middle Aged ,medicine.disease ,Endometrial Neoplasms ,B vitamins ,Endocrinology ,Logistic Models ,Oncology ,chemistry ,Haplotypes ,Methylenetetrahydrofolate reductase ,Case-Control Studies ,biology.protein ,Female ,business - Abstract
Folate plays an important role in carcinogenesis. The enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR), encoded by the MTHFR gene, is involved in this process. We investigated both the independent and joint effects of dietary folate and other methyl-related nutrients, as well as three polymorphisms of MTHFR (677C>T, 1298A>C, and 1793G>A), on endometrial cancer risk in a population-based case-control study. Between 1997 and 2003, 1,204 newly diagnosed endometrial cancer cases and 1,212 controls were recruited among women between the ages of 30 and 69 years in urban Shanghai, China. Information on dietary intake of folate and other methyl-related nutrients, including vitamin B2 (riboflavin), vitamin B6, vitamin B12, and methionine, was derived from a validated food frequency questionnaire. Genotyping was completed on 1,041 cases and 1,030 controls for MTHFR 677C>T (rs1801133), 1298A>C (rs1801131), and 1793 G>A (rs22749746). Haplotype estimation of the three single-nucleotide polymorphisms was performed using PHASE software. Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated to evaluate associations of nutrients, MTHFR genotypes, and haplotypes with endometrial cancer risk. A significant inverse association between dietary folate intake and endometrial cancer risk was observed among all subjects and non–B vitamin supplement users. The greatest reduction in endometrial cancer risk was observed among non-users of supplements in the highest quartile of dietary folate intake (OR, 0.5; 95% CI, 0.4-0.7) as compared with those in the lowest quartile. Dietary intake of folate cofactors (methionine, vitamin B2, vitamin B6, and vitamin B12) was not related to risk of endometrial cancer. No association was observed between endometrial cancer and the MTHFR 677C>T, 1298 A>C, and 1793G>A polymorphisms or derived haplotypes. Among non-users of supplements, however, the 1298C and 1793A alleles were associated with a lower risk of endometrial cancer among women with high dietary folate intake but related to a higher risk among those with low dietary folate intake (Pinteraction = 0.08 and 0.03, respectively). Further analysis showed that the lowest risk (OR, 0.6; 95% CI, 0.4-1.1) was among women with the 1298C allele and the highest intake of both folate and riboflavin (Pinteraction = 0.04). A similar association was observed for the 1793A allele (Pinteraction = 0.03). Our findings suggest that folate intake may decrease the risk of endometrial cancer and modify the effect of MTHFR polymorphisms on risk. (Cancer Epidemiol Biomarkers Prev 2007;16(2):281–7)
- Published
- 2007
30. Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study
- Author
-
Ying Zheng, Wei Lu, Yu-Tang Gao, Kai Gu, Sang Ah Lee, Xiao-Ou Shu, Wei Zheng, Qi Dai, Asha R. Kallianpur, and Zhi Xian Ruan
- Subjects
Vitamin ,Adult ,Risk ,Cancer Research ,medicine.medical_specialty ,China ,Population ,Physiology ,Breast Neoplasms ,Heme ,chemistry.chemical_compound ,Breast cancer ,Internal medicine ,Surveys and Questionnaires ,medicine ,Humans ,Risk factor ,education ,Aged ,Animal fat ,education.field_of_study ,business.industry ,Case-control study ,Cancer ,Middle Aged ,Micronutrient ,medicine.disease ,Oxidants ,Dietary Fats ,Diet ,Endocrinology ,Oncology ,chemistry ,Case-Control Studies ,Female ,business ,Iron, Dietary - Abstract
Dietary fats and other constituents have been studied extensively in relation to breast cancer risk. Iron, an essential micronutrient with pro-oxidant properties, has received little attention, and specific fats may augment its toxicity. We investigated the effects of iron and fats from various food sources on the risk of breast cancer. Participants in a population-based case–control study, 3,452 breast cancer cases, and 3,474 age-frequency-matched controls, completed in-person interviews, including a detailed food-frequency questionnaire. Plant- and animal-derived iron and fat intakes were derived from dietary intake data and food composition tables. Unconditional logistic regression models were used to study the independent and interactive effects of different forms of iron and fats on breast cancer risk. Animal-derived (largely heme) iron intake was positively associated with breast cancer risk (P trend
- Published
- 2007
31. Oral contraceptive and IUD use and endometrial cancer: a population-based case-control study in Shanghai, China
- Author
-
Meng Hua, Tao, Wang Hong, Xu, Wei, Zheng, Zuo-Feng, Zhang, Yu-Tang, Gao, Zhi Xian, Ruan, Jia Rong, Cheng, Jing, Gao, Yong Bing, Xiang, and Xiao Ou, Shu
- Subjects
Adult ,China ,Time Factors ,Socioeconomic Factors ,Risk Factors ,Case-Control Studies ,Smoking ,Humans ,Female ,Middle Aged ,Contraceptives, Oral ,Endometrial Neoplasms ,Intrauterine Devices - Abstract
Oral contraceptive (OC) and intrauterine device (IUD) use have been shown to be protective factors for endometrial cancer in several epidemiological studies; however, few studies have been conducted in Chinese populations. We evaluated the association between OC and IUD use and endometrial cancer risk in a population-based case-control study among Chinese women in Shanghai, China. The study included 1,204 newly diagnosed endometrial cancer cases and 1,212 age frequency-matched healthy controls. Logistic regression models were used to estimate adjusted odds ratios (OR) and their 95% confidence intervals (95% CI). In our study population, 18.5% cases and 24.9% controls reported having ever used OCs with an OR of 0.75 (95% CI, 0.60-0.93), after adjusting for known risk or protective factors for endometrial cancer. The risk of endometrial cancer decreased with long-term use of OCs with the OR for more than 72 months of use being 0.50 (95% CI, 0.30-0.85). The effect of OC use remained 25 or more years after cessation of use; the associated OR was 0.57 (95% CI = 0.42-0.78) as compared to nonusers. Similarly, fewer cases than controls had ever used IUD, with the multivariable adjusted OR being 0.53 (95% CI = 0.43-0.65). A reduction in risk was observed regardless the duration of use or age at first and last use. These results suggest that OC and IUD use may confer long-term protection against endometrial cancer.
- Published
- 2006
32. [Green tea consumption and the risk of endometrial cancer: a population-based case-control study in urban Shanghai]
- Author
-
Jing, Gao, Yong-bing, Xiang, Wang-hong, Xu, Chang-xia, Shao, Zhi-xian, Ruan, Jia-rong, Cheng, Xiao-ou, Shu, and Yu-tang, Gao
- Subjects
Adult ,China ,Logistic Models ,Tea ,Risk Factors ,Case-Control Studies ,Surveys and Questionnaires ,Urban Health ,Humans ,Female ,Middle Aged ,Aged ,Endometrial Neoplasms - Abstract
To assess the effect of tea consumption on the risk of endometrial cancer.In a population based case-control study conducted in urban Shanghai, face-to-face interviews were completed for 995 incidence cases aged 30 - 69 from January 1997 to December 2002 and 1087 controls that frequency-matched to cases on age. Unconditional logistic model was used for analysis.An inverse association was observed in tea drinking and endometrial cancer risk. Compared to non-tea drinkers, regular tea drinkers had reduced risk of endometrial cancer (OR = 0.74; 95% CI: 0.54 - 1.01) in premenopausal women. Green tea had a protective effect on endometrial cancer among non-smoking or non-alcohol drinking women (OR = 0.77, P = 0.0199) and the ORs reduced with the increasing concentration of tea being served (P for trend = 0.0493). The multivariate ORs for drinking green tea7 times/week andor= 7 times/week were 0.90 (95% CI: 0.53 - 1.54) and 0.76 (95% CI: 0.60 - 0.95) with the trend test of P = 0.0163.Tea drinking, with green tea in particurlar, seemed to have weak but inverse association with endometrial cancer risk, but this effect of protection might only limit to premenopausal women.
- Published
- 2005
33. Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study
- Author
-
Qi Dai, Xiao-Ou Shu, Wei Zheng, Zhi Xian Ruan, Yu-Tang Gao, Qiuyin Cai, and Sonia M. Boyapati
- Subjects
Oncology ,Adult ,Cancer Research ,medicine.medical_specialty ,Estrogen receptor ,Breast Neoplasms ,Cohort Studies ,Breast cancer ,Waist–hip ratio ,Internal medicine ,Medicine ,Humans ,Survival analysis ,Gynecology ,business.industry ,Hazard ratio ,Cancer ,Soy Foods ,Middle Aged ,medicine.disease ,Survival Analysis ,Diet ,Cohort ,Female ,business ,Body mass index ,Follow-Up Studies - Abstract
Soy and its constituents have been shown in many in vivo and in vitro studies and in some epidemiological studies to have anti-cancer effects. Some soy constituents, however, also stimulate cell proliferation, which has raised concerns in promoting soy intake among breast cancer survivors. To investigate whether soy intake may be associated with breast cancer survival, we evaluated data from a cohort of 1459 breast cancer patients who participated in the Shanghai Breast Cancer Study between 1996 and 1998. Usual soy food intake was assessed using a validated food frequency questionnaire at baseline. The median follow-up time for this cohort of women was 5.2 years. We found that soy intake prior to cancer diagnosis was unrelated to disease-free breast cancer survival (adjusted hazard ratio [HR]=0.99, 95% confidence interval [CI], 0.73-1.33 for the highest tertile compared to the lowest tertile). The association between soy protein intake and breast cancer survival did not differ according to ER/PR status, tumor stage, age at diagnosis, body mass index (BMI), waist to hip ratio (WHR), or menopausal status. Additionally, the soy-survival association did not appear to vary according to XbaI or PvuII polymorphisms in ER-alpha, or C(14206)T, G(25652)A, or A(50766)G polymorphisms in ER-beta. These data suggest that soyfoods do not have an adverse effect on breast cancer survival.
- Published
- 2005
34. Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival
- Author
-
Sonia M, Boyapati, Xiao-Ou, Shu, Zhi Xian, Ruan, Qiuyin, Cai, Jeffrey R, Smith, Wanqing, Wen, Yu-Tang, Gao, and Wei, Zheng
- Subjects
Adult ,Polymorphism, Genetic ,Time Factors ,Genotype ,Estrogen Receptor alpha ,Breast Neoplasms ,DNA, Neoplasm ,Middle Aged ,Survival Analysis ,Cohort Studies ,Gene Frequency ,Humans ,Female ,Deoxyribonucleases, Type II Site-Specific ,Dinucleotide Repeats ,Alleles ,Follow-Up Studies - Abstract
The effects of estrogens are mediated primarily through estrogen receptor (ER) in breast tissue, and polymorphisms in the ER genes may alter the functions of these receptors. Polymorphisms in the ER-alpha gene have been reported to be associated with breast cancer risk. However, to our knowledge, no study has been published on the relation between ER-alpha gene polymorphisms and breast cancer survival.To determine whether three common polymorphisms in the ER-alpha gene, PvuII, XbaI, and GT dinucleotide repeats are associated with breast cancer survival, we evaluated data from a cohort of 1,069 breast cancer patients who participated in the Shanghai Breast Cancer Study between 1996 and 1998. The median follow-up time for this cohort of women was 5.2 years.No overall association was observed between ER gene polymorphisms and breast cancer survival. The genotype associations, however, were modified by ER status in breast cancer tissues. Comparing those with the PP genotype to the pp genotype of the PvuII polymorphism, the hazard ratios (HR) of dying were 3.30 [95% confidence interval (95% CI), 1.42-7.69] and 0.54 (95% CI, 0.24-1.23), respectively, for participants with ER-negative breast cancer and ER-positive breast cancer. Similarly, compared with those with no (GT)(23) alleles, carrying one or two (GT)(23) alleles of the GT repeat polymorphism was related to a HR of 1.48 (95% CI, 0.77-2.87) for ER-negative breast cancer and a HR of 0.25 (95% CI, 0.09-0.69) for ER-positive cancer. The effect of ER on breast cancer survival was also modified by genotypes of ER-alpha gene. Tests for multiplicative interaction were highly significant.These data suggest that the ER-alpha gene polymorphisms and ER status may have an interactive effect on breast cancer survival.
- Published
- 2005
35. Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma
- Author
-
Fan Jin, B S Zhi-Xian Ruan, Yu-Tang Gao, Wei Zheng, M.P.H. Gong Yang M.D., Qiuyin Cai, and Xiao-Ou Shu
- Subjects
Oncology ,Adult ,Cancer Research ,medicine.medical_specialty ,Genotype ,medicine.medical_treatment ,Breast Neoplasms ,GSTP1 ,Breast cancer ,Risk Factors ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Medicine ,Humans ,Neoplasm Invasiveness ,Allele ,Glutathione Transferase ,Polymorphism, Genetic ,business.industry ,Hazard ratio ,Carcinoma ,Cancer ,Middle Aged ,medicine.disease ,Survival Analysis ,Radiation therapy ,Treatment Outcome ,Case-Control Studies ,Cancer research ,Female ,business ,Breast carcinoma ,Tamoxifen ,Acyltransferases ,medicine.drug - Abstract
BACKGROUND It has been suggested that genetic polymorphisms in certain glutathione-S-transferase (GST) genes reduce the effectiveness of detoxifying cytotoxins generated by chemotherapeutic agents, potentially resulting in enhanced clinical responses to chemotherapy. METHODS The authors evaluated common polymorphisms in the GSTM1, GSTT1, and GSTP1 genes for associations with overall survival in 1034 patients with invasive breast carcinoma who were recruited into the Shanghai Breast Cancer Study between 1996 and 1998, treated with chemotherapy, and followed for a median of 5.3 years. RESULTS After adjusting for age, tumor stage, and the use of radiotherapy and tamoxifen, women who were homozygous for the variant GSTP1105Val allele had a 60% reduction in mortality risk compared with women who were homozygous for the Ile allele (hazard ratio, 0.4; 95% confidence interval, 0.2–0.8). No association was found with respect to any of the GSTM1 or GSTT1 genotypes. CONCLUSIONS The results of the current study indicate a potential role for GSTP1 polymorphism in predicting the clinical outcomes of patients with breast carcinoma who are treated with chemotherapy. Cancer 2005. © 2004 American Cancer Society.
- Published
- 2004
36. [Trends analysis of common urologic neoplasm incidence of elderly people in Shanghai, 1973-1999]
- Author
-
Wei, Zhang, Yong-Bing, Xiang, Zhen-Wei, Liu, Ru-Rong, Fang, Zhi-Xian, Ruan, Lu, Sun, Li-Feng, Gao, Fan, Jin, and Yu-Tang, Gao
- Subjects
Adult ,Aged, 80 and over ,Male ,China ,Incidence ,Age Factors ,Prostatic Neoplasms ,Middle Aged ,Kidney Neoplasms ,Sex Factors ,Urinary Bladder Neoplasms ,Humans ,Female ,Aged - Abstract
Few studies on trend analysis in cancer incidence of the elderly people in China. The purpose of this study was to analyze time trends in urologic cancer incidence of the elderly people during the period 1973-1999 in Shanghai.The registered cancer cases were coded according to the 3-digit rubrics of the ninth revision of the International Classification of Diseases (ICD-9). Population estimates were based on periodic censuses, with age- and sex-specific annual estimates derived by linear inter- and extrapolation for the remaining years. The age-standardized rates adjusted to the world population were calculated for nine 3-year periods. Annual percent changes in incidence were estimated by means of a linear regression of the respective rates on the mid-point of calendar years, weighted by the number of cases.During the 27-year period, cancers of prostate, bladder, and kidney have risen substantially among elderly male residents in Shanghai. The annual percent changes were 6.60%, 1.15%, and 5.30%, respectively. Among the elderly women, the rate of kidney cancer increased rapidly, with the annual percent change of 4.87%. The 75 years and older age group in women had substantial increases in incidence rates of bladder cancer.From 1973 to 1999, the incidence rates of the commonly urologic cancers increased substantially among the elderly residents in Shanghai, except for female bladder cancer.
- Published
- 2004
37. Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study
- Author
-
Xiao-Ou, Shu, Yu-Tang, Gao, Qiuyin, Cai, Larry, Pierce, Hui, Cai, Zhi-Xian, Ruan, Gong, Yang, Fan, Jin, and Wei, Zheng
- Subjects
Adult ,Transforming Growth Factor beta1 ,Polymorphism, Genetic ,Transforming Growth Factor beta ,Humans ,Breast Neoplasms ,Female ,Middle Aged ,Disease-Free Survival - Abstract
The effect of genetic polymorphisms in the TGF-beta1 gene at codon 10 (T+29C), codon 25 (G+74C), and the promoter region [C --T at -509 from the transcription site, (C-509T)] on breast cancer survival was evaluated among a cohort of 1111 patients. The median follow-up time for the cohort was 5.17 years after cancer diagnosis. No DNA sequence variation at codon 25 of the TGF-beta1 gene was found, whereas polymorphisms in C-509T and T+29C were in strong linkage disequilibrium. Patients who carried the C allele of T+29C polymorphism had a reduced 5-year disease-free survival rate (75.6% for T/C, and 78.2% for C/C) compared with the T/T genotype (85.1%; P, 0.04); the age-adjusted hazard ratio was 1.5 (95% confidence interval, 1.1-2.2). Adjustment for clinical prognostic factors slightly attenuated the association (hazard ratio, 1.4, 95% confidence interval, 1.0-1.9). Our study suggests that genetic polymorphisms in the TGF-beta1 gene may play a role in breast cancer progression.
- Published
- 2004
38. Occupations and breast cancer risk among Chinese women in urban Shanghai
- Author
-
Kathleen M. Gardner, Qi Dai, Yu-Tang Gao, Zhi-Xian Ruan, James R. Hussey, Fan Jin, Xiao-Ou Shu, Wei Zheng, and Shirley J. Thompson
- Subjects
Adult ,medicine.medical_specialty ,China ,Urban Population ,Population ,Breast Neoplasms ,Breast cancer ,Risk Factors ,Occupational Exposure ,Epidemiology ,medicine ,Odds Ratio ,Humans ,Risk factor ,Occupations ,education ,education.field_of_study ,Anthropometry ,business.industry ,Confounding ,Public Health, Environmental and Occupational Health ,Case-control study ,Cancer ,Odds ratio ,Middle Aged ,medicine.disease ,Surgery ,Occupational Diseases ,Female ,business ,Demography - Abstract
Background Although, an elevated risk of breast cancer has been suggested for a number of occupations, many earlier studies were limited by selection biases, the incomplete assessment of job histories, and the inability to control for confounding. Methods We examined the relationship between occupational history and breast cancer risk using data from a population-based case-control study of 1,458 cases and 1,556 age-matched controls (90% response rate) conducted in Shanghai, China. Unconditional logistic regression models were used to derive odds ratios (ORs) and 95% confidence intervals (95% CIs) of breast cancer risk associated with occupations and duration of employment adjusting for non-occupational risk factors. Results The following occupations were found to be associated with an increased risk of breast cancer: laboratory technicians (OR 9.94, 95% CI 1.20–82.37), telephone and telegraph operators (OR 4.63, 95% CI 1.85–11.59), leather and fur processors (OR 3.25, 95% CI 1.11–9.53), and glass-manufacturing workers (OR 2.08, 95% CI 1.14–3.82). A dose–response pattern for years of employment was observed for leather and fur processors (P = 0.02) and glass-manufacturing workers (P = 0.01). Stratified analyses also revealed dose–response relationships between the risk of breast cancer and years of employment as inspector and product analysts among pre-menopausal women (P = 0.02), and as farmers among post-menopausal women (P = 0.04). Conclusions This study found that several occupations are associated with an increased risk of breast cancer among women. Studies examining various occupational exposures in these high-risk occupations are warranted to identify carcinogens that may play a role in the increased breast cancer risk. Am. J. Ind. Med. 42: 296–308, 2002. © 2002 Wiley-Liss, Inc.
- Published
- 2002
39. Use of Complementary and Alternative Medicine by Chinese Women with Breast Cancer
- Author
-
Yong Cui, Xiao-Ou Shu, Yutang Gao, Wanqing Wen, Zhi-Xian Ruan, Fan Jin, and Wei Zheng
- Subjects
Cancer Research ,Oncology - Published
- 2004
40. Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study
- Author
-
Qi Dai, Zhi Xian Ruan, Jia Rong Cheng, Yu-Tang Gao, Wanghong Xu, Yong-Bing Xiang, Wei Zheng, and Xiao-Ou Shu
- Subjects
Adult ,endocrine system ,China ,medicine.medical_specialty ,Waist ,Phytoestrogens ,chemistry.chemical_compound ,fluids and secretions ,Risk Factors ,Environmental health ,Odds Ratio ,Humans ,Medicine ,Risk factor ,Aged ,General Environmental Science ,Gynecology ,urogenital system ,business.industry ,Incidence ,Endometrial cancer ,Incidence (epidemiology) ,Urban Health ,General Engineering ,Case-control study ,food and beverages ,General Medicine ,Odds ratio ,Middle Aged ,medicine.disease ,Isoflavones ,Endometrial Neoplasms ,Cancer registry ,chemistry ,Case-Control Studies ,Papers ,General Earth and Planetary Sciences ,Female ,Plant Preparations ,Soybeans ,business - Abstract
Objective To evaluate the association of intake of soya food, a rich source of phytoestrogens, with the risk of endometrial cancer. Design Population based case-control study, with detailed information on usual soya food intake over the past five years collected by face to face interview using a food frequency questionnaire. Setting Urban Shanghai, China. Participants 832 incident cases of endometrial cancer in women aged of 30 to 69 years diagnosed during 1997-2001 and identified from the Shanghai Cancer Registry; 846 control women frequency matched to cases on age and randomly selected from the Shanghai Residential Registry. Main outcome measures Odds ratios for risk of endometrial cancer in women with different intakes of soya foods. Results Regular consumption of soya foods, measured as amount of either soya protein or soya isoflavones, was inversely associated with the risk of endometrial cancer. Compared with women with the lowest quarter of intake, the adjusted odds ratio of endometrial cancer was reduced from 0.93 to 0.85 and 0.67 with increasing quarter of soya protein intake (P for trend 0.01). A similar inverse association was observed for soya isoflavones and soya fibre intake. The inverse association seemed to be more pronounced among women with high body mass index and waist:hip ratio. Conclusion Regular intake of soya foods is associated with a reduced risk of endometrial cancer.
- Published
- 2004
41. Association of the Progesterone Receptor Gene With Endometrial Cancer Risk in a Chinese Population.
- Author
-
Wang-Hong Xu, Ji-rong Long, Wei Zheng, Zhi-xian Ruan, Qiuyin Cai, Jia-rong Cheng, Yong-Bing Xiang, and Xiao-Ou Shu
- Subjects
PROGESTERONE receptors ,GENE expression ,MEDICAL research ,CANCER ,DNA ,GENETIC polymorphisms - Abstract
The article presents the study conducted regarding the role of progesterone receptor (PGR) gene in endometrial cancer risk development in China. The study which collected DNA samples and information from Shanghai Endometrial Cancer Study aims to determine the association of PGR with the cancer risk in the Chinese population. The result shows that the gene is associated with the risk due to the polymorphism in the PGR region.
- Published
- 2009
- Full Text
- View/download PDF
42. Association of Thymidylate Synthase Gene with Endometrial Cancer Risk in a Chinese Population.
- Author
-
Wang-Hong Xu, Ji-Rong Long, Wei Zheng, Zhi-Xian Ruan, Qiuyin Cai, Jia-Rong Cheng, Gen-Ming Zhao, Yong-Bing Xiang, and Xiao-Ou Shu
- Abstract
The article presents a study which aims to investigate the connection between the risk of acquiring endometrial cancer and thymidylate synthase (TYMS) gene among the citizens in China. Researchers have used population-based case control study of this type of cancer and the participants were interviewed. DNA samples have also collected from the participants to determine the link. Moreover, researchers have determined the relation between TYMS and endometrial cancer in women.
- Published
- 2009
- Full Text
- View/download PDF
43. Drinking Green Tea Modestly Reduces Breast Cancer Risk.
- Author
-
Shrubsole, Martha J., Wei Lu, Zhi Chen, Xiao Ou Shu, Ying Zheng, Qi Dai, Qiuyin Cai, Kal Gu, Zhi Xian Ruan, Yu-Tang Gao, and Wei Zheng
- Subjects
GREEN tea ,BREAST cancer risk factors ,POLYPHENOLS ,CATECHOL - Abstract
Green tea is a commonly consumed beverage in China. Epidemiological and animal data suggest tea and tea polyphenols may be preventive against various cancers, including breast cancer. Catechol-O-methyltransferase (COMT) catalyzes catechol estrogens and tea polyphenols. The COMT rs4680 AA genotype leads to lower COMT activity, which may affect the relationship between green tea consumption and breast cancer risk. We evaluated whether regular green tea consumption was associated with breast cancer risk among 3454 incident cases and 3474 controls aged 20-74 y in a population-based case-control study conducted in Shanghai, China during 1996-2005. All participants were interviewed in person about green tea consumption habits, including age of initiation, duration of use, brew strength, and quantity of tea. Odds ratios (OR) and 95% Cl were calculated for green tea consumption measures and adjusted for age and other confounding factors. Compared with nondrinkers, regular drinking of green tea was associated with a slightly decreased risk for breast cancer (OR, 0.88; 95% Cl, 0.79-0.98). Among premenopausal women, reduced risk was observed for years of green tea drinking (P-trend = 0.02) and a dose-response relationship with the amount of tea consumed per month was also observed (P-trend = 0.046). COMT rs4680 genotypes did not have a modifying effect on the association of green tea intake with breast cancer risk. Drinking green tea may be weakly associated with a decreased risk of breast cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
44. Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study.
- Author
-
Sang-Ah Lee, Yu-Tang Gao, Wei Lu, Ying Zheng, Zhi-Xian Ruan, Qi Dai, Kai Gu, Xiao-Ou Shu, and Wei Zheng
- Subjects
MEDICAL research ,BREAST cancer ,DISEASE risk factors ,THERAPEUTICS - Abstract
Abstract Background  Dietary fats and other constituents have been studied extensively in relation to breast cancer risk. Iron, an essential micronutrient with pro-oxidant properties, has received little attention, and specific fats may augment its toxicity. We investigated the effects of iron and fats from various food sources on the risk of breast cancer. Methods  Participants in a population-based caseâcontrol study, 3,452 breast cancer cases, and 3,474 age-frequency-matched controls, completed in-person interviews, including a detailed food-frequency questionnaire. Plant- and animal-derived iron and fat intakes were derived from dietary intake data and food composition tables. Unconditional logistic regression models were used to study the independent and interactive effects of different forms of iron and fats on breast cancer risk. Results  Animal-derived (largely heme) iron intake was positively associated with breast cancer risk (P trend P Conclusions  A high intake of animal-derived (heme) iron may be associated with an increased risk of primary breast cancer in Chinese women, and saturated and mono-unsaturated fats that are also derived from animal sources may augment this effect. Combined reductions in animal-derived iron and fat consumption have the potential to reduce breast cancer risk. [ABSTRACT FROM AUTHOR]
- Published
- 2008
45. Dietary Folate Intake, MTHFR Genetic Polymorphisms, and the Risk of Endometrial Cancer among Chinese Women.
- Author
-
Wang-Hong Xu, Shrubsole, Martha J., Yong-Bing Xiang, Qiuyin Cai, Gen-ming Zhao, Zhi-xian Ruan, Jia-rong Cheng, Wei Zheng, and Xiao Ou Shu
- Abstract
The article focuses on a case-control study conducted among Chinese women to examine the independent and joint effects of folate intake and methylenetetrahydrofolate reductase (MTHFR) genotypes on the risk of endometrial cancer. Folate could have anticarcinogenic properties in endometrial cancer risk based on the study. The study indicates that dietary folate intake is reversely associated with the risk of endometrial cancer, especially among women whose folate intake is derived solely from food.
- Published
- 2007
- Full Text
- View/download PDF
46. Weight history and risk of endometrial cancer among Chinese women.
- Author
-
Wang Hong Xu, Yong Bing Xiang, Wei Zheng, Xianglan Zhang, Zhi Xian Ruan, Jia Rong Cheng, Yu-Tang Gao, and Xiao-Ou Shu
- Abstract
Background Adult obesity is a well-established risk factor for endometrial cancer. However, little is known about the association of endometrial cancer risk with body size early in life and weight change during adulthood. We investigated whether women with greater early-age body size or with greater weight change during adulthood have an increased risk of endometrial cancer.Methods We analysed data from a population-based case–control study of endometrial cancer conducted between 1997 and 2001 in Shanghai, China. Included in this analysis were 832 endometrial cancer cases aged 30–69 years and 846 population controls. Information on weight and height history from adolescence through adulthood was obtained via structured in-person interviews. A logistic regression model was used to derive odds ratios (ORs) and 95% confidence intervals (CIs) for endometrial cancer in association with adolescent and adult adiposity, as well as adult body weight change. All ORs were adjusted for age, education, menstrual status, duration of menstruation, number of pregnancies, oral contraceptive use, and family history of cancer.Results Perceived weights and heights during puberty that were greater than average were associated with a modestly increased risk of cancer. The association for perceived weight was substantially weakened after adjustment for current body mass index (BMI). High BMI at all adult ages significantly predicted endometrial cancer risk, with recent BMI being the strongest predictor. Further analyses disclosed that weight gain during adulthood, particularly during the peri-menopausal period (age 40–50 years), was associated with a significantly elevated risk of endometrial cancer, even among currently non-obese women. Gaining >5 kg between age 40 and 50 was related to ORs of 2.3 (95% CI 1.4–3.9) for women with a BMI < 25 kg/m2 and 2.0 (95% CI 1.3–3.0) for women with BMI ≥ 25 kg/m2.Conclusions Adult weight gain, particularly during the peri-menopausal period, plays a significant role in the development of endometrial cancer risk. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
47. Association of Overweight with Breast Cancer Survival.
- Author
-
Meng-Hua Tao, Xiao-Ou Shu, Zhi Xian Ruan, Yu-Tang Gao, and Wei Zheng
- Subjects
OBESITY ,BREAST cancer ,CANCER in women ,BODY weight ,WOMEN'S health ,EPIDEMIOLOGICAL research - Abstract
The authors investigated the association between overweight at the time of or soon after cancer diagnosis and survival in a cohort of 1,455 breast cancer patients aged 2564 years. The patients were recruited into the Shanghai Breast Cancer Study (Shanghai, China), a population-based case-control study, between August 1996 and March 1998. The median follow-up time for this cohort was 5.1 years (19962002) after breast cancer diagnosis, and 240 deaths were identified. Being overweight at cancer diagnosis or soon afterward, as measured by body mass index (BMI; weight (kg)/height (m)2), was associated with poorer overall survival and disease-free survival. Five-year survival rates were 86.5%, 83.8%, and 80.1% for subjects whose BMIs were <23.0, 23.024.9, and =25.0, respectively (p = 0.02); the corresponding 5-year disease-free survival rates were 81.9%, 78.1%, and 76.6% (p = 0.05). The inverse association between BMI and survival persisted after adjustment for age at diagnosis and other known prognostic factors for breast cancer, including disease stage. The authors found neither waist:hip ratio nor waist circumference to be independently associated with overall survival or disease-free survival. These results suggest that excess weight may be an independent predictor of breast cancer survival among Chinese women. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
48. Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study.
- Author
-
Sonia M. Boyapati, Xiao-ou Shu, Zhi Xian Ruan, Qi Dai, Qiuyin Cai, Yu-tang Gao, and Wei Zheng
- Subjects
BREAST cancer ,CANCER patients ,CANCER diagnosis ,CELL proliferation - Abstract
Abstract Soy and its constituents have been shown in many in vivo and in vitro studies and in some epidemiological studies to have anti-cancer effects. Some soy constituents, however, also stimulate cell proliferation, which has raised concerns in promoting soy intake among breast cancer survivors. To investigate whether soy intake may be associated with breast cancer survival, we evaluated data from a cohort of 1459 breast cancer patients who participated in the Shanghai Breast Cancer Study between 1996 and 1998. Usual soy food intake was assessed using a validated food frequency questionnaire at baseline. The median follow-up time for this cohort of women was 5.2?years. We found that soy intake prior to cancer diagnosis was unrelated to disease-free breast cancer survival (adjusted hazard ratio [HR]=0.99, 95% confidence interval [CI], 0.731.33 for the highest tertile compared to the lowest tertile). The association between soy protein intake and breast cancer survival did not differ according to ER/PR status, tumor stage, age at diagnosis, body mass index (BMI), waist to hip ratio (WHR), or menopausal status. Additionally, the soy-survival association did not appear to vary according to XbaI or PvuII polymorphisms in ER-alpha, or C(14206)T, G(25652)A, or A(50766)G polymorphisms in ER-beta. These data suggest that soyfoods do not have an adverse effect on breast cancer survival. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
49. Effect of Adiposity and Fat Distribution on Endometrial Cancer Risk in Shanghai Women.
- Author
-
Wang Hong Xu, Matthews, Charles E., Yong Bing Xiang, Wei Zheng, Zhi Xian Ruan, Jia Rong Cheng, Yu Tang Gao, and Xiao Ou Shu
- Subjects
HUMAN body composition ,BODY mass index ,CASE-control method ,TUMORS ,OBESITY ,CONTRACEPTIVE drugs ,CANCER in women - Abstract
The authors conducted a population-based case-control study of 832 endometrial cancer cases and 846 frequency-matched controls in Shanghai, China (1997–2001), to examine the association of overall adiposity and body fat distribution with disease risk. Overall adiposity was estimated using weight and body mass index (BMI); upper body fat distribution was evaluated using waist circumference and waist:hip ratio. Overall and upper-body obesity were both associated with an elevated risk of endometrial cancer. Adjusted odds ratios and 95% confidence intervals for highest-versus-lowest quartile comparisons were 2.6 (95% confidence interval (CI): 2.0, 3.5) for weight, 2.9 (95% CI: 2.2, 3.9) for BMI, 4.7 (95% CI: 3.4, 6.4) for waist circumference, and 3.5 (95% CI: 2.6, 4.8) for waist:hip ratio. The positive associations with weight and BMI vanished after results were controlled for waist circumference, while associations with waist circumference and waist:hip ratio persisted after adjustment for BMI. The positive association with upper-body obesity was more pronounced among younger women, women who had never used oral contraceptives, and women with a history of diabetes mellitus (p for multiplicative interaction < 0.05). Upper-body obesity was related to increased risk among women with low BMI. These results suggest that obesity, particularly upper-body fat deposition, is associated with an increased risk of endometrial cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
50. MTHFR genotypes and breast cancer survival after surgery and chemotherapy: a report from the Shanghai Breast Cancer Study.
- Author
-
Martha J. Shrubsole, Xiao Ou Shu, Zhi Xian Ruan, Qiuyin Cai, Hui Cai, Qi Niu, Yu-Tang Gao, and Wei Zheng
- Abstract
Summary Methylenetetrahydrofolate reductase (MTHFR) regulates the intracellular folates pool for DNA synthesis and methylation. Sequence variations in MTHFR (nucleotides 677 (C?T) and 1298 (A?C)) result in allozymes with decreased activity. The 677TT genotype is associated with increased toxicity of methotrexate and increased clinical response to 5-fluorouracil in treatment of cancers including breast cancer. We evaluated MTHFR genotypes and breast cancer survival in a cohort of 1067 Chinese women diagnosed with breast cancer between 1996 and 1998 who received surgery and chemotherapy. Life table method was used to calculate 5-year survival rates. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) after adjusting for potential confounding factors. Median follow-up time was 5.2 years; 5-year survival was 84.6%. Sixty-six percent carried a 677T allele and 31% carried a 1298 C allele. We found that overall 5-year breast cancer survival did not differ significantly across all genotypes (85.3% for 677 CC and 83.8% for 677TT; 83.8% for 1298 AA and 79.1% for 1298 CC). However, carrying the 677T allele was associated with non-significant increased risk of death for subjects with late stage disease (stages III–IV) (HR=1.80, 95% CI: 0.79–4.14 for TT vs. CC, p for trend=0.15), particularly among those who had survived past the second year (HR=2.97, 95% CI: 1.10–7.98, p for trend=0.04). The A1298C genotypes were not significantly associated with risk of death. This study suggests that the MTHFR C677T polymorphisms may affect long-term survival from advanced breast cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.